載入...
TNF inhibitor therapy for rheumatoid arthritis
Immunotherapy has markedly improved treatment outcomes in rheumatoid arthritis (RA). Tumor necrosis factor (TNF)-α antagonists, such as infliximab (IFX), etanercept (ETN), adalimumab (ADA), golimumab (GOLI) and certolizumab pegol (CZP) have been widely used for the treatment of RA. IFX provides sign...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956207/ https://ncbi.nlm.nih.gov/pubmed/24648915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2012.42 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|